E-viri
PDF
Recenzirano
Odprti dostop
-
Venter, Willem D.F; Moorhouse, Michelle; Sokhela, Simiso; Fairlie, Lee; Mashabane, Nkuli; Masenya, Masebole; Serenata, Celicia; Akpomiemie, Godspower; Qavi, Ambar; Chandiwana, Nomathemba; Norris, Shane; Chersich, Matthew; Clayden, Polly; Abrams, Elaine; Arulappan, Natasha; Vos, Alinda; McCann, Kaitlyn; Simmons, Bryony; Hill, Andrew
The New England journal of medicine, 08/2019, Letnik: 381, Številka: 9Journal Article
Treatment of HIV-1 infection in sub-Saharan Africa has many challenges. In this report, the safety and efficacy of three different regimens are assessed in HIV-1–infected persons in South Africa: tenofovir alafenamide fumarate (TAF)–emtricitabine (FTC)–dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)–FTC–DTG, and the local standard-of-care regimen (TDF–FTC–efavirenz).
